Brind.

Sera and Myriad Genetics are appointing a board of directors to guide the company, both operating in diagnostics and life sciences.

1 report, 1 independent Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sera and Myriad Genetics are appointing a board of directors to guide the company, both operating in diagnostics and life sciences.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped